Inactive Instrument

Highlights ALPHANCO VEN

Equities

Marvel Biotechnology Inc. completed the acquisition of Alphanco Venture Corp. (TSXV:AVC.P) for CAD 3.8 million in a reverse merger transaction.	13/06/21	CI
Alphanco Venture Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2021	10/06/21	CI
Alphanco Venture Corp. Reports Earnings Results for the Second Quarter Ended January 31, 2021	22/03/21	CI
Marvel Biotechnology Inc. entered into a binding letter agreement to acquire Alphanco Venture Corp. (TSXV:AVC.P) in a reverse merger transaction.	02/11/20	CI
Alphanco Venture Corp. Reports Earnings Results for the Full Year Ended July 31, 2020	16/10/20	CI
Alphanco Venture Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2020	12/05/20	CI
Alphanco Venture Corp. Reports Earnings Results for the Second Quarter Ended January 31, 2020	08/03/20	CI
Alphanco Venture Corp. Reports Earnings Results for the First Quarter Ended October 31, 2019	17/12/19	CI
Alphanco Venture Corp. Reports Earnings Results for the Full Year Ended July 31, 2019	07/11/19	CI
Alphanco Venture Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2019	04/06/19	CI
Alphanco Venture Corp. Reports Earnings Results for the Second Quarter Ended January 31, 2019	25/03/19	CI
Alphanco Venture Corp. has completed an IPO in the amount of CAD 0.4 million.	28/02/19	CI
Alphanco Venture Corp. has filed an IPO in the amount of CAD 0.4 million.	20/12/18	CI
Alphanco Venture Intends To Seek Acquisitions	20/12/18	CI

No results for this search